401 related articles for article (PubMed ID: 34968454)
1. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
[TBL] [Abstract][Full Text] [Related]
2. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
Wang L; Zhu L; Liang C; Huang X; Liu Z; Huo J; Zhang Y; Zhang Y; Chen L; Xu H; Li X; Xu L; Kuang M; Wong CC; Yu J
J Hepatol; 2023 Nov; 79(5):1185-1200. PubMed ID: 37459919
[TBL] [Abstract][Full Text] [Related]
3. Targeting m
Bao Y; Zhai J; Chen H; Wong CC; Liang C; Ding Y; Huang D; Gou H; Chen D; Pan Y; Kang W; To KF; Yu J
Gut; 2023 Aug; 72(8):1497-1509. PubMed ID: 36717220
[TBL] [Abstract][Full Text] [Related]
4. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
7. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
8. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
[TBL] [Abstract][Full Text] [Related]
9. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
[TBL] [Abstract][Full Text] [Related]
11. YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of
Pi J; Wang W; Ji M; Wang X; Wei X; Jin J; Liu T; Qiang J; Qi Z; Li F; Liu Y; Ma Y; Si Y; Huo Y; Gao Y; Chen Y; Dong L; Su R; Chen J; Rao S; Yi P; Yu S; Wang F; Yu J
Cancer Res; 2021 May; 81(10):2651-2665. PubMed ID: 32788173
[TBL] [Abstract][Full Text] [Related]
12. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
13. RNA N
Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
[TBL] [Abstract][Full Text] [Related]
14. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
[TBL] [Abstract][Full Text] [Related]
15. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
[TBL] [Abstract][Full Text] [Related]
16. YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.
Bai Y; Yang C; Wu R; Huang L; Song S; Li W; Yan P; Lin C; Li D; Zhang Y
Front Oncol; 2019; 9():332. PubMed ID: 31131257
[TBL] [Abstract][Full Text] [Related]
17. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
[No Abstract] [Full Text] [Related]
18. N
Chen D; Cheung H; Lau HC; Yu J; Wong CC
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884552
[TBL] [Abstract][Full Text] [Related]
19. YTHDF1-regulated expression of TEAD1 contributes to the maintenance of intestinal stem cells.
Jiang D; Hou J; Qian Y; Gao Y; Gao X; Wei S
Biochem Biophys Res Commun; 2021 Jun; 557():85-89. PubMed ID: 33862464
[TBL] [Abstract][Full Text] [Related]
20. Oncogene c-Myc promotes epitranscriptome m
Nishizawa Y; Konno M; Asai A; Koseki J; Kawamoto K; Miyoshi N; Takahashi H; Nishida N; Haraguchi N; Sakai D; Kudo T; Hata T; Matsuda C; Mizushima T; Satoh T; Doki Y; Mori M; Ishii H
Oncotarget; 2018 Jan; 9(7):7476-7486. PubMed ID: 29484125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]